Orthofix International N.V. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
28,812.00
8,537.00
2,809.00
3,056.00
6,223.00
13,811
Depreciation, Depletion & Amortization
23,542.00
22,878.00
20,923.00
20,841.00
20,124.00
18,659
Other Funds
2,293.00
10,456.00
34,810.00
2,407.00
4,245.00
27,107
Funds from Operations
33,609.00
18,186.00
27,718.00
56,797.00
70,524.00
56,916
Changes in Working Capital
33,433.00
32,772.00
15,506.00
2,279.00
31,552.00
6,998
Net Operating Cash Flow
67,042.00
50,958.00
43,224.00
59,076.00
38,972.00
49,918
Capital Expenditures
29,678.00
18,525.00
27,899.00
18,334.00
16,948.00
Purchase/Sale of Investments
1,374.00
1,457.00
15,250.00
3,613.00
-
Net Investing Cash Flow
31,052.00
19,950.00
38,349.00
21,947.00
16,474.00
Issuance/Reduction of Debt, Net
16.00
20,000.00
1,825.00
-
-
Net Financing Cash Flow
38,353.00
19,994.00
25,114.00
46,112.00
3,538.00
Net Change in Cash
1,843.00
7,891.00
26,848.00
9,722.00
27,216.00
Free Cash Flow
42,255.00
32,889.00
16,027.00
42,644.00
24,307.00
Deferred Taxes & Investment Tax Credit
2,829.00
7,053.00
1,156.00
10,460.00
21,286.00
2,661
Other Sources
-
32.00
4,800.00
-
474.00
Change in Capital Stock
36,044.00
10,462.00
7,871.00
43,705.00
7,783.00
Exchange Rate Effect
520.00
3,123.00
3,141.00
739.00
1,180.00

About Orthofix International

View Profile
Address
3451 Plano Parkway
Lewisville Texas 75056
United States
Employees -
Website http://www.orthofix.com
Updated 07/08/2019
Orthofix Medical, Inc. engages in the research, development, and market of orthopedic solutions. It operates through the following business segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment produces and sells devices for bone fusion enhancement in cervical and lumbar spine through the pulsed electromagnetic technology.